Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 45

    1.

    Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.

    Sidharta PN, Rave K, Heinemann L, Chiossi E, Krähenbühl S, Dingemanse J.

    Br J Clin Pharmacol. 2009 Oct;68(4):502-10.PMID: 19843053 [PubMed - in process]Related articles

    2.

    AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics.

    de la Peña A, Seger M, Rave K, Heinemann L, Silverman B, Muchmore DB.

    Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S75-80.PMID: 19772452 [PubMed - in process]Related articles

    3.

    Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes.

    Hompesch M, Kollmeier A, Rave K, Heinemann L, Mitnick M, Davies S, Strack T.

    Diabetes Technol Ther. 2009 May;11(5):307-13.PMID: 19537357 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin.

    Rave K, Potocka E, Boss AH, Marino M, Costello D, Chen R.

    Diabetes Obes Metab. 2009 Jul;11(7):715-20. Epub 2009 May 19.PMID: 19476477 [PubMed - in process]Related articles

    5.

    Renal glucose excretion and tubular reabsorption rate related to blood glucose in subjects with type 2 diabetes with a critical reappraisal of the "renal glucose threshold" model.

    Wolf S, Rave K, Heinemann L, Roggen K.

    Horm Metab Res. 2009 Aug;41(8):600-4. Epub 2009 May 5.PMID: 19418417 [PubMed - indexed for MEDLINE]Related articles

    6.

    PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.

    Heise T, Brugger A, Cook C, Eckers U, Hutchcraft A, Nosek L, Rave K, Troeger J, Valaitis P, White S, Heinemann L.

    Diabetes Obes Metab. 2009 May;11(5):455-9. Epub 2009 Feb 19.PMID: 19236443 [PubMed - in process]Related articles

    7.

    An Analysis of How to Measure Glucose during Glucose Clamps: Are Glucose Meters Ready for Research?

    Hompesch M, Rave K.

    J Diabetes Sci Technol. 2008 Sep;2(5):896-8.PMID: 19885275 [PubMed - in process]Free article

    8.

    Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.

    Arnolds S, Rave K.

    Lancet. 2008 Aug 2;372(9636):370-1; author reply 372. No abstract available. PMID: 18675680 [PubMed - indexed for MEDLINE]Related articles

    9.

    Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects.

    Becker RH, Frick AD, Teichert L, Nosek L, Heinemann L, Heise T, Rave K.

    Diabetes Obes Metab. 2008 Nov;10(11):1105-13. Epub 2008 Mar 18.PMID: 18355326 [PubMed - indexed for MEDLINE]Related articles

    10.

    Inhaled technosphere(r) insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.

    Rave K, Heise T, Heinemann L, Boss AH.

    J Diabetes Sci Technol. 2008 Mar;2(2):205-12.PMID: 19885344 [PubMed - in process]Free article

    11.

    Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.

    Becker RH, Frick AD, Nosek L, Heinemann L, Rave K.

    Diabetes Care. 2007 Oct;30(10):2506-7. Epub 2007 Aug 3. No abstract available. PMID: 17675541 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.

    Rave K, Heise T, Pfützner A, Boss AH.

    Diabetes Care. 2007 Sep;30(9):2307-8. Epub 2007 Jun 22. No abstract available. PMID: 17586744 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.

    Rave K, Roggen K, Dellweg S, Heise T, tom Dieck H.

    Br J Nutr. 2007 Nov;98(5):929-36. Epub 2007 Jun 12.PMID: 17562226 [PubMed - indexed for MEDLINE]Related articles

    14.

    AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.

    Rave K, de la Peña A, Tibaldi FS, Zhang L, Silverman B, Hausmann M, Heinemann L, Muchmore DB.

    Diabetes Care. 2007 Jul;30(7):1777-82. Epub 2007 Apr 24.PMID: 17456839 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.

    Rave K, Klein O, Frick AD, Becker RH.

    Diabetes Care. 2006 Aug;29(8):1812-7.PMID: 16873785 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp study.

    Rave K, Nosek L, Posner J, Heise T, Roggen K, van Hoogdalem EJ.

    Nephrol Dial Transplant. 2006 Aug;21(8):2166-71. Epub 2006 Apr 20.PMID: 16627603 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.

    Rave KM, Nosek L, de la Peña A, Seger M, Ernest CS 2nd, Heinemann L, Batycky RP, Muchmore DB.

    Diabetes Care. 2005 Oct;28(10):2400-5.PMID: 16186270 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.

    Danne T, Becker RH, Heise T, Bittner C, Frick AD, Rave K.

    Diabetes Care. 2005 Sep;28(9):2100-5.PMID: 16123473 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.

    Rave K, Flesch S, Kühn-Velten WN, Hompesch BC, Heinemann L, Heise T.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):459-64.PMID: 15915547 [PubMed - indexed for MEDLINE]Related articles

    20.

    Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin.

    Rave K, Bott S, Heinemann L, Sha S, Becker RH, Willavize SA, Heise T.

    Diabetes Care. 2005 May;28(5):1077-82.PMID: 15855570 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes.

    Poll L, Wittsack HJ, Willers R, Mödder U, Heinemann L, Kapitza C, Rave K.

    Diabetes Technol Ther. 2004 Dec;6(6):844-9.PMID: 15684638 [PubMed - indexed for MEDLINE]Related articles

    22.

    Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.

    Rave K, Nosek L, Heinemann L, Gonzales C, Ernest CS, Chien J, Muchmore D.

    Diabet Med. 2004 Jul;21(7):763-8.PMID: 15209771 [PubMed - indexed for MEDLINE]Related articles

    23.

    Dependency of the metabolic effect of sc-injected human regular insulin on intra-abdominal fat in patients with type 2 diabetes.

    Rave K, Nosek L, Heinemann L, Frick A, Becker R, Kapitza C.

    Horm Metab Res. 2004 May;36(5):307-11.PMID: 15156411 [PubMed - indexed for MEDLINE]Related articles

    24.

    Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.

    Kapitza C, Heise T, Fishman RS, Shapiro DA, Gopalakrishnan V, Rave K, Bott S, Perera AD, Heinemann L.

    Diabetes Technol Ther. 2004 Apr;6(2):119-27.PMID: 15117578 [PubMed - indexed for MEDLINE]Related articles

    25.

    Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal.

    Kapitza C, Rave K, Ostrowski K, Heise T, Heinemann L.

    Diabet Med. 2004 May;21(5):500-1. No abstract available. PMID: 15089801 [PubMed - indexed for MEDLINE]Related articles

    26.

    Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers.

    Rave K, Nosek L, Heinemann L, Frick A, Becker R.

    Diabetes Metab. 2003 Sep;29(4 Pt 1):430-1. No abstract available. PMID: 14526272 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetes.

    Heise T, Bott S, Rave K, Dressler A, Rosskamp R, Heinemann L.

    Diabet Med. 2002 Jun;19(6):490-5.PMID: 12060061 [PubMed - indexed for MEDLINE]Related articles

    28.

    Effect of C-peptide on glucose metabolism in patients with type 1 diabetes.

    Forst T, Rave K, Pfuetzner A, Buchholz R, Pohlmann T, Löbig M, Heinemann L.

    Diabetes Care. 2002 Jun;25(6):1096-7. No abstract available. PMID: 12032122 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.

    Steiner S, Pfützner A, Wilson BR, Harzer O, Heinemann L, Rave K.

    Exp Clin Endocrinol Diabetes. 2002 Jan;110(1):17-21.PMID: 11835120 [PubMed - indexed for MEDLINE]Related articles

    30.

    Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force.

    Heinemann L, Krämer U, Klötzer HM, Hein M, Volz D, Hermann M, Heise T, Rave K; Non-Invasive Task Force.

    Diabetes Technol Ther. 2000 Summer;2(2):211-20.PMID: 11469261 [PubMed - indexed for MEDLINE]Related articles

    31.

    Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

    Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT.

    Diabetes Care. 2001 May;24(5):886-90.PMID: 11347749 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

    Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T.

    Diabetes Care. 2000 Sep;23(9):1343-7.PMID: 10977030 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    A cross-over evaluation of different methods and devices to measure blood pressure in type 1 diabetic patients with nephropathy.

    Heise T, Magnusson K, Gröbel B, Heinemann L, Rave K, Bender R, Sawicki PT.

    Blood Press Monit. 2000 Jun;5(3):175-80.PMID: 10915231 [PubMed - indexed for MEDLINE]Related articles

    34.

    Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

    Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T.

    Diabetes Care. 2000 May;23(5):644-9.PMID: 10834424 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Lack of effects of the beta3-adrenoreceptor agonist UL-TG 307 on insulin sensitivity and insulin secretion in Type 2 diabetic patients.

    Rave K, Heise T, Clausson P, Hirschberger S, Heinemann L.

    Exp Clin Endocrinol Diabetes. 1999;107(7):442-6.PMID: 10595595 [PubMed - indexed for MEDLINE]Related articles

    36.

    Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers.

    Rave K, Heise T, Weyer C, Sawicki P, Heinemann L.

    Exp Clin Endocrinol Diabetes. 1999;107(5):313-7.PMID: 10482044 [PubMed - indexed for MEDLINE]Related articles

    37.

    Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.

    Rave K, Bender R, Heise T, Sawicki PT.

    J Hypertens. 1999 May;17(5):597-601.PMID: 10403602 [PubMed - indexed for MEDLINE]Related articles

    38.

    Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.

    Rave K, Heinemann L, Puhl L, Gudat U, Woodworth JR, Weyer C, Heise T.

    Diabetes Care. 1999 May;22(5):865-6. No abstract available. PMID: 10332707 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Electrocardiographic changes during insulin-induced hypoglycemia in healthy subjects.

    Meinhold J, Heise T, Rave K, Heinemann L.

    Horm Metab Res. 1998 Nov;30(11):694-7.PMID: 9918388 [PubMed - indexed for MEDLINE]Related articles

    40.

    Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.

    Rave K, Heise T, Weyer C, Herrnberger J, Bender R, Hirschberger S, Heinemann L.

    Diabet Med. 1998 Sep;15(9):747-51.PMID: 9737803 [PubMed - indexed for MEDLINE]Related articles

    41.

    Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.

    Heinemann L, Weyer C, Rave K, Stiefelhagen O, Rauhaus M, Heise T.

    Exp Clin Endocrinol Diabetes. 1997;105(3):140-4.PMID: 9228509 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Post-exposure drug prevention of HIV infection]

    Rave K, Jablonowski H, Ross B, Philipp T.

    Med Klin (Munich). 1996 Sep 15;91(9):589-99. Review. German. No abstract available. PMID: 8984318 [PubMed - indexed for MEDLINE]Related articles

    43.

    Successful short-term treatment with granulocyte-macrophage colony-stimulating factor of neutropenia due to cytotoxic chemotherapy of chronic lymphocytic leukemia.

    Rave K, Brittinger G.

    Ann Hematol. 1991 Dec;63(6):333. No abstract available. PMID: 1756194 [PubMed - indexed for MEDLINE]Related articles

    44.

    Atrial natriuretic factor in various stages of diabetic nephropathy.

    Sawicki PT, Heinemann L, Rave K, Hohmann A, Berger M.

    J Diabet Complications. 1988 Oct-Dec;2(4):207-9.PMID: 2976764 [PubMed - indexed for MEDLINE]Related articles

    45.

    [Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy]

    Sawicki P, Heinemann L, Rave K, Berger M.

    Z Kardiol. 1988;77 Suppl 2:111-3. German. PMID: 2970165 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...